Opiant Pharmaceuticals, Inc. announced the appointments of Aziz Mottiwala as Opiant’s Chief Commercial Officer, and Rahsaan Thompson, Esq., as General Counsel, two newly created positions, effective September 16, 2019. Mr. Mottiwala will be responsible for building Opiant’s commercial organization and pre-commercial activities, as appropriate. Mr. Thompson will be responsible for all legal aspects of corporate strategy, intellectual property, transactions, compliance and regulatory matters. Both Mr. Mottiwala and Mr. Thompson will report directly to Roger Crystal, M.D., Chief Executive Officer of Opiant. Mr. Mottiwala has more than 20 years of leadership experience in the biopharmaceutical industry, across all areas of commercialization. Prior to joining Opiant, he was Senior Vice President and Head of Commercial at Avanir Pharmaceuticals. Mr. Mottiwala also spent over 10 years at Allergan, most recently as Vice President of Marketing for the company’s Eye Care Franchise. Mr. Thompson joins Opiant with more than a decade of experience in corporate counsel roles, most recently serving as Vice President, Law, for Actelion U.S., where he spent the previous eight years.